World

At least 14 dead in Pakistan bus accident

Nov 14, 2024

Punjab [Pakistan], November 14: At least 14 people have been confirmed killed and many more missing and presumed dead after a bus crashed into the Indus river in northern Pakistan, according to local authorities.
The driver lost control of the vehicle when travelling at high speed, according to a statement from authorities in the Gilgit Baltistan region, where the accident occurred on Tuesday.
The bus was carrying around two dozen people, members of a wedding procession, according to local media. The number of fatalities has not been confirmed, with some reports placing the figure as high as 26.
Rescue crews have already recovered 13 bodies from the river, while 12 passengers remain missing and are presumed to have not survived the accident due to freezing temperatures in the area, according to the Pakistani news outlet Dawn.
The bride survived the accident and was taken to hospital, but later succumbed to her injuries, Dawn reports. The bus was heading towards Chakwal, a city in Pakistan's Punjab province, when it careened off the road and into the river from Telchi bridge in the Diamer district at about 1pm local time (08:00 GMT), according to local broadcaster Geo.
Pakistani President Asif Ali Zardari expressed his "deep grief over the loss of precious lives in the accident" in a post on social media platform X.
He also emphasised the "need to speed up" search and rescue operations for those yet to be found.
Source: Qatar Tribune

More news

Concept Medical Announces Successful SIRONA Trial Results, Demonstrating Sirolimus-Coated Balloon as a Promising Alternative for PAD Treatment

Tampa (Florida) [US], January 7: Concept Medical Inc., a global leader in innovative drug-delivery technology, proudly reports positive outcomes from the SIRONA (Head-to-Head Comparison of SIROlimus versus Paclitaxel Drug-Eluting BallooNAngioplasty in the Femoropopliteal Artery) RCT, which show that its sirolimus-coated balloons (SCB) (MagicTouch -PTA) provide patency and functional benefits on par with paclitaxel-coated balloons for patients suffering from peripheral artery disease (PAD). The 1-year data was presented by Principal Investigator Prof. Ulf Teichgraber at the TCT USA 2024 conference in a Late-Breaking Clinical Trials Session (LBCT). Coverage by TCTMD has highlighted these findings, underscoring sirolimus-based therapy as a viable new option in femoropopliteal interventions.

Jan 07, 2025